Article Information
History
- April 17, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Mikel Ariz, PhD1,2,†,
- Martín Martínez, PhD3,†,
- Ignacio Alvarez, MSc4,
- Maria A. Fernández-Seara, PhD5,6,
- The Catalonian Neuroimaging Parkinson’s disease Consortium,
- Pau Pastor, MD, PhD7,*,
- Maria A. Pastor, MD, PhD3,8,* and
- Carlos Ortiz de Solórzano, PhD1,6,*,§
- 1Ciberonc and Solid Tumours and Biomarkers Program, CIMA University of Navarra, Pamplona, Spain
- 2Department of Electrical, Electronic and Communications Engineering, Public University of Navarre, Pamplona, Spain
- 3Neuroimaging Laboratory, University of Navarra, School of Medicine, Pamplona, Spain
- 4Movement Disorders Unit, Neurology, University Hospital Mútua de Terrassa, Terrassa, Barcelona, Spain
- 5Department of Radiology, Clínica Universidad de Navarra, Pamplona, Spain
- 6IdiSNA, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain
- 7Unit of Neurodegenerative diseases, Department of Neurology, University Hospital Germans Trias i Pujol, and Germans Trias i Pujol Research Institute (IGTP). Badalona, Barcelona, Spain
- 8Movement Disorders Unit, Neurology, University of Navarra
- ↵§Correspondence to:
Carlos Ortiz de Solórzano, Imaging Laboratory, CIMA University of Navarra, University of Navarra Campus, 31008 Pamplona, Spain, e-mail: codesolorzano{at}unav.es
- 9Neurology Department. Hospital Universitari Vall D’Hebron. Neurodegenerative Diseases Research Group. Vall D’Hebron Research Institute (VHIR). Barcelona. Spain
- 10Parkinson and Movement disorders Unit, Hospital Quirón-Teknon, Barcelona, Spain
- 11Unit of Neurodegenerative diseases, Department of Neurology, University Hospital Germans Trias i Pujol, and Germans Trias i Pujol Research Institute (IGTP), Badalona, Barcelona, Spain
- 12Movement Disorders Unit, Neurology, Hospital Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain
- 13Neurology, Complex Hospitalari Moisès Broggi, Sant Joan Despí, Barcelona, Spain
- 14Movement Disorders Unit, Neurology, Hospital Universitari Mútua de Terrassa, Terrassa, Barcelona, Spain
- 15Movement Disorders Unit, Neurology, Hospital del Mar, Barcelona, Spain
- 16Parkinson’s disease and Movement Disorders Unit, Neurology, Hospital Clínic de Barcelona, Barcelona, Catalonia, Spain
- 17Neurology Service, Hospital General de Granollers, Granollers, Barcelona, Spain
↵†,* These authors contributed equally to this work.
Posted April 17, 2023.
Automatic segmentation and quantification of nigrosome-1 neuromelanin and iron in MRI: a candidate biomarker for Parkinson’s disease
